Hims & Hers Health vs Teladoc Health
Teladoc Health reported revenue of $2.5 billion in fiscal 2025, about the same as Hims & Hers Health's $2.3 billion in fiscal 2025. Hims & Hers Health's revenue grew 59.0% in its latest year, and Teladoc Health's fell 1.5%. Hims & Hers Health had an operating margin of 4.5%, against -10.4% at Teladoc Health. Free cash flow was $57 million at Hims & Hers Health and $285 million at Teladoc Health.
Side by side
| Hims & Hers Health | Teladoc Health | |
|---|---|---|
| Latest fiscal year | FY2025, Dec 31, 2025 | FY2025, Dec 31, 2025 |
| Revenue | $2.3B | $2.5B |
| Revenue growth | 59.0% | −1.5% |
| Revenue growth a year, last 5 years | 73.6% | 18.3% |
| Gross margin | 73.8% | — |
| Operating margin | 4.5% | −10.4% |
| Net margin | 5.5% | −7.9% |
| Free cash flow | $57M | $285M |
| Free cash flow margin | 2.5% | 11.3% |
| Return on capital | 19.0% | −12.5% |
| Net debt to EBITDA | 2.5x | 2.1x |
| Dividends and buybacks | $90M | $0M |
| Change in diluted share count | 9.1% | 3.3% |
| Last close | $19.73 | $8.80 |
| P/E at the last close | — | — |
| Insider trades, last 12 months | bought $1.2 million, sold $19.1 million | bought $69,400, sold $2.4 million |
| Piotroski F-score | 4 of 9 | 6 of 8 |
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.
Ten years
Revenue
US$ billions, fiscal years
Hims & Hers HealthTeladoc Health
Operating margin
Percent of revenue
Hims & Hers HealthTeladoc Health
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
Hims & Hers HealthTeladoc Health
Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the Hims & Hers Health and Teladoc Health pages.